[The apoB genotype and the efficacy of hypolipidemic therapy].

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[The apoB genotype and the efficacy of hypolipidemic therapy].

TSitologiia i genetika - 1 Jan 2000

Tseluĭko V I, Kravchenko N A, Chernyshov V a, Maksimova N A, Nazarenko I L

Abstract excerpt

Several men were examined for association between restriction fragment length polymorphism (RELP) Xba I (exon 26) number of tandem repeats in 3'-hypervariable region of the apolipoprotein-B gene and serum levels of cholesterol and triglyceride. These two types of polymorphism were studied. An association of the Xba I site and alleles containing more repeats in the 3'-hypervariable region with higher cholesterol...

Topics

Adult
Aged
Angina Pectoris
Apolipoproteins B
Base Sequence
DNA Primers
Fenofibrate
Genotype
Humans
Hyperlipidemias
Hypolipidemic Agents
Lipids
Male
Middle Aged
Molecular Sequence Data
Myocardial Ischemia
Phenotype
Polymerase Chain Reaction

Source

Open in PubMed

Identifiers

PMID: 9695263

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics